| Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Δ9-tetrahydrocannabinol AA Boucher, JC Arnold, L Duffy, PR Schofield, J Micheau, T Karl Psychopharmacology 192, 325-336, 2007 | 209 | 2007 |
| Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus DS Carson, GE Hunt, AJ Guastella, L Barber, JL Cornish, JC Arnold, ... Addiction biology 15 (4), 448-463, 2010 | 154 | 2010 |
| The First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity SM Wilkinson, H Gunosewoyo, ML Barron, A Boucher, M McDonnell, ... ACS chemical neuroscience 5 (5), 335-339, 2014 | 132 | 2014 |
| Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test AA Boucher, JC Arnold, GE Hunt, A Spiro, J Spencer, C Brown, ... Neuroscience 189, 170-177, 2011 | 128 | 2011 |
| Cognition in transmembrane domain neuregulin 1 mutant mice L Duffy, E Cappas, D Lai, AA Boucher, T Karl Neuroscience 170 (3), 800-807, 2010 | 110 | 2010 |
| The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids AA Boucher, GE Hunt, J Micheau, XF Huang, IS McGregor, T Karl, ... International Journal of Neuropsychopharmacology 14 (5), 631-643, 2011 | 80 | 2011 |
| Heterozygous neuregulin 1 mice display greater baseline and Δ9-tetrahydrocannabinol-induced c-Fos expression AA Boucher, GE Hunt, T Karl, J Micheau, IS McGregor, JC Arnold Neuroscience 149 (4), 861-870, 2007 | 78 | 2007 |
| Enhanced Brain Disposition and Effects of Δ9-Tetrahydrocannabinol in P-Glycoprotein and Breast Cancer Resistance Protein Knockout Mice AS Spiro, A Wong, AA Boucher, JC Arnold PloS one 7 (4), e35937, 2012 | 62 | 2012 |
| The differential binding of antipsychotic drugs to the ABC transporter p-glycoprotein predicts cannabinoid–antipsychotic drug interactions NI Brzozowska, EJ de Tonnerre, KM Li, XS Wang, AA Boucher, ... Neuropsychopharmacology 42 (11), 2222-2231, 2017 | 40 | 2017 |
| Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice JR Spencer, KME Darbyshire, AA Boucher, MA Kashem, LE Long, ... Frontiers in cellular neuroscience 7, 15, 2013 | 39 | 2013 |
| Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice TW Chohan, AA Boucher, JR Spencer, MS Kassem, AA Hamdi, T Karl, ... Schizophrenia bulletin 40 (6), 1272-1284, 2014 | 38 | 2014 |
| Chronic treatment with Δ9-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain AA Boucher, L Vivier, M Metna-Laurent, L Brayda-Bruno, N Mons, ... Behavioural pharmacology 20 (1), 45-55, 2009 | 34 | 2009 |
| Adolescent neuregulin 1 heterozygous mice display enhanced behavioural sensitivity to methamphetamine JR Spencer, KME Darbyshire, AA Boucher, JC Arnold Progress in Neuro-Psychopharmacology and Biological Psychiatry 39 (2), 376-381, 2012 | 14 | 2012 |
| ACS Chem SM Wilkinson, H Gunosewoyo, ML Barron, A Boucher, M McDonnell, ... Neurosci, 2017 | 9 | 2017 |
| The 2nd Schizophrenia International Research Society Conference, 10–14 April 2010, Florence, Italy: Summaries of oral sessions M Baharnoori, C Bartholomeusz, AA Boucher, L Buchy, C Chaddock, ... Schizophrenia research 124 (1-3), e1-e62, 2010 | 8 | 2010 |
| P2X7 receptor knockout mice display less aggressive biting behaviour correlating with increased brain activation in the piriform cortex KL Smith, SM Todd, A Boucher, MR Bennett, JC Arnold Neuroscience Letters 714, 134575, 2020 | 4 | 2020 |
| Heterozygous neuregulin 1 mice display altered sensitivity to the neurobehavioural effects of cannabinoids JC Arnold, AA Boucher, GE Hunt, IS McGregor, T Karl, J Micheau Behavioural Pharmacology 18, S10-S10, 2007 | 2 | 2007 |
| The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions J Arnold, AA Boucher, N Brzozowska, P Callaghan, E de Tonnerre, ... Nature Publishing Group, 2017 | | 2017 |
| S. 12.1-CANNABINOIDS: A RISK FACTOR FOR A GENETIC MOUSE MODEL OF SCHIZOPHRENIA? T Karl, L Long, A Boucher, I McGregor, XF Huang, J Arnold Behavioural Pharmacology 24, e14, 2013 | | 2013 |
| Cannabinoids: risk factors for a neuregulin 1 mouse model of schizophrenia? T Karl, L Long, R Chesworth, AA Boucher, A Spiro, XF Huang, J Arnold | | 2011 |
